| Exome sequencing and the management of neurometabolic disorders M Tarailo-Graovac, C Shyr, CJ Ross, GA Horvath, R Salvarinova, XC Ye, ... New England Journal of Medicine 374 (23), 2246-2255, 2016 | 214 | 2016 |
| Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2011 | 73 | 2011 |
| Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich Annals of human genetics 74 (4), 340-350, 2010 | 55 | 2010 |
| Characterization of the genetic profile of CYP2C19 in two South African populations BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ... Pharmacogenomics 11 (8), 1095-1103, 2010 | 52 | 2010 |
| Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ... BMC medical genetics 14 (1), 20, 2013 | 41 | 2013 |
| Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment BI Drögemöller, GEB Wright, DJH Niehaus, R Emsley, L Warnich Pharmacogenetics and genomics 23 (12), 666-674, 2013 | 35 | 2013 |
| Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ... The American Journal of Human Genetics 104 (6), 1116-1126, 2019 | 33 | 2019 |
| Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ... JAMA oncology 3 (11), 1558-1562, 2017 | 33 | 2017 |
| Characterization of the genetic variation present in CYP3A4 in three South African populations BI Drogemoller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ... Frontiers in Genetics 4, 17, 0 | 33* | |
| De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome S Langlois, M Tarailo-Graovac, B Sayson, B Drögemöller, A Swenerton, ... European Journal of Human Genetics 24 (6), 949-953, 2016 | 26 | 2016 |
| Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis K Kowalec, GEB Wright, BI Drögemöller, F Aminkeng, AP Bhavsar, ... Nature genetics 50 (8), 1081-1085, 2018 | 25 | 2018 |
| Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ... Clinical Cancer Research 24 (8), 1866-1871, 2018 | 24 | 2018 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 23 | 2019 |
| PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights DL Johnstone, HH Al-Shekaili, M Tarailo-Graovac, NI Wolf, AS Ivy, ... Brain 142 (3), 542-559, 2019 | 22 | 2019 |
| Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ... New England Journal of Medicine 380 (15), 1433-1441, 2019 | 21 | 2019 |
| Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications BI Drögemöller, GEB Wright, DJH Niehaus, RA Emsley, L Warnich Pharmacogenomics 12 (12), 1717-1728, 2011 | 21 | 2011 |
| Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort GEB Wright, DJH Niehaus, L van der Merwe, L Koen, LJ Korkie, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (1), 163-169, 2012 | 20 | 2012 |
| Germline de novo mutations in ATP1A1 cause renal hypomagnesemia, refractory seizures, and intellectual disability KP Schlingmann, S Bandulik, C Mammen, M Tarailo-Graovac, R Holm, ... The American Journal of Human Genetics 103 (5), 808-816, 2018 | 17 | 2018 |
| Considerations for rare variants in drug metabolism genes and the clinical implications BI Droegemoeller, GEB Wright, L Warnich Expert opinion on drug metabolism & toxicology 10 (6), 873-884, 2014 | 17 | 2014 |
| CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines BI Drögemöller, GEB Wright, J Shih, JG Monzon, KA Gelmon, CJD Ross, ... Breast cancer research and treatment 173 (3), 521-532, 2019 | 15 | 2019 |
